
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Batm Advanced Communications Ld | LSE:BVC | London | Ordinary Share | IL0010849045 | ORD ILS0.01 |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
20.50 | 20.80 | 21.75 | 20.50 | 21.75 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Communications Services, Nec | USD 116.12M | USD 244k | USD 0.0006 | 346.67 | 90.7M |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
16:35:17 | UT | 4,513 | 20.65 | GBX |
Date | Time | Source | Headline |
---|---|---|---|
30/11/2023 | 07:03 | UKREG | BATM Advanced Communications Ld Block Listing Application |
27/11/2023 | 07:00 | UKREG | BATM Advanced Communications Ld Block Listing Interim Review |
30/10/2023 | 10:47 | ALNC | ![]() |
30/10/2023 | 07:00 | UKREG | BATM Advanced Communications Ld BATM receives $3m cyber security order |
23/10/2023 | 15:19 | ALNC | ![]() |
23/10/2023 | 06:04 | UKREG | BATM Advanced Communications Ld ADOR Diagnostics secures $7.5m investment |
16/10/2023 | 14:30 | UKREG | BATM Advanced Communications Ld Holding(s) in Company |
16/10/2023 | 10:59 | ALNC | ![]() |
16/10/2023 | 06:00 | UKREG | BATM Advanced Communications Ld New Edgility order for US Emergency.. |
09/10/2023 | 15:27 | DJN | Israel Companies Look to Keep Operations Running After Hamas Attack -- At a.. |
Batm Advanced Communicat... (BVC) Share Charts1 Year Batm Advanced Communicat... Chart |
|
1 Month Batm Advanced Communicat... Chart |
Intraday Batm Advanced Communicat... Chart |
Date | Time | Title | Posts |
---|---|---|---|
01/12/2023 | 09:30 | Coronavirus Investment - BATM | 615 |
29/11/2023 | 18:59 | Batm Advanced - A New Beginning | 23,150 |
23/9/2022 | 08:58 | BATM * BATM * BATM * BATM ******BUNG A ROCKET IN YER PORTFILIOS | 49 |
12/6/2020 | 16:27 | BVC over-ramped and over-valued! | 120 |
15/4/2020 | 09:44 | BATM - Broadband bright future | 22,489 |
Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
---|---|---|---|---|
2023-12-01 16:35:17 | 20.65 | 4,513 | 931.93 | UT |
2023-12-01 16:04:36 | 20.80 | 3,055 | 635.44 | AT |
2023-12-01 15:11:52 | 20.77 | 481 | 99.92 | O |
2023-12-01 14:46:57 | 20.62 | 378 | 77.93 | O |
2023-12-01 14:41:23 | 20.95 | 5 | 1.05 | AT |
Top Posts |
---|
Posted at 02/12/2023 08:20 by Batm Advanced Communicat... Daily Update Batm Advanced Communications Ld is listed in the Communications Services, Nec sector of the London Stock Exchange with ticker BVC. The last closing price for Batm Advanced Communicat... was 20.95p.Batm Advanced Communicat... currently has 436,039,124 shares in issue. The market capitalisation of Batm Advanced Communicat... is £90,696,138. Batm Advanced Communicat... has a price to earnings ratio (PE ratio) of 346.67. This morning BVC shares opened at 21.75p |
Posted at 30/11/2023 09:26 by echoridge I think what gb is trying to say is that punters are using spread betting firms like 'spreadex' to short BATM over time in just enough size to keep a lid on the price and/or consistently drive it lower. That (very unlikely) scenario then gets even more discombobulated in the mind of people like gb and it becomes Spreadex itself which is shorting BATM in sufficient size that they then SOMEHOW set about to corruptly manipulate the share price lower. 'spreadex' then almost becomes synonymous with 'evil manipulator' generally for the conspiracy theorists like gb, similar to the way right wing nutjobs use George Soros as a provocative shorthand for all things lefty-communist conspiracy to undermine capitalism. |
Posted at 30/11/2023 09:17 by echoridge honestly gb, I really don't want to do this. You didn't even bother reading my response thoroughly. As for your 'daily trading patterns' question, I'll answer this way: yes, I have and I can tell you in simple terms that you had at least part of the correct answer earlier. BATM is down over the past x months partly because of disappointed small shareholders selling out but mainly for reasons that have to do with other factors that I and others have listed many, many times which you seem to be resistant to understanding. I can't say 'spreadex', or short-selling generally, are NEVER a factor in the daily share price movements, but it is not a relevant factor overall, no. |
Posted at 30/11/2023 08:44 by echoridge First off, watch the language, you ignorant b1tch. Second, the greater the % that shares and options represent of an executive's compensation, the more aligned they're going to be with shareholders in focusing on improving the share price. That's just a simple, objective reality, which makes your ignorant, over-the-top response that much more ludicrous. I concede entirely that this has not yet worked but that does not change the internal logic of my comment. Finally, the reasoning behind your spreadex conspiracy theory is so dopey, it's not worth fully engaging with. BATM's daily volume is simply too low at this point to avoid the small cap malaise in these markets. However, given all the news that's already come and the odds of major items highlighted by FSE and Resistance that are likely to come soon as well, as well as a solid volume pickup lately in Israel, I am hopeful for the months to come. We shall see.... |
Posted at 02/11/2023 21:35 by pockstones How many of you on this website are remunerated by Batm ?Only asking as the commentary is as one sided as the ongoing collapse in the share price |
Posted at 30/10/2023 08:23 by homeboy since i last posted on here the share price has gone down even further, the good old fse is still wasting his life cutting and pasting tedious reams of stuff to try and prop up the share price, lol, and all the other deluded clowns are still here trying to talk this up whilst ignoring the fact that the market thinks this badly managed company is a dogso they've sold more stuff to their single customer, lol, very bad business model, probably a charity purchase that chicken carcass boiling vat business isn't worth a dime, peanuts revenue and margin and ador is still sucking up funds and in development, that'll be years if it ever gets off the ground and edgility not exactly flying off the shelves is it badly managed and wrecked their london listing in favour of tase, are they mad, you lot certainly are, back to your delusions then forever living in hope, lol, the market not buying this dog is it all in my wonderful opinionated opinion |
Posted at 13/10/2023 19:40 by echoridge I'm going to gather my thoughts over the weekend, but for now, all I have to 'say' about today's price action, volume, trade distribution, level of retail activity, the relative uselessness of the corporate broker, overall, continued heavy small cap selling generally, and the apparent absence of any meaningful institutional support is: how in the f-ck did this share price close down less than a penny, after actually going blue late in the session?!? Amazing poop..... |
Posted at 13/10/2023 09:03 by echoridge All we know for sure is this move was made far worse by a very badly handled block of around 300k shares in the opening auction offered 'at market', which pretty much guaranteed the market would be maximally chaotic for the first few hours. This likely was the result of a clueless institution who never trades BATM, though it could have been the work of someone who wanted maximal damage (less likely). Anyway, the share price fightback, on the back of pretty decent buying is encouraging. note: of all the firms that have advertised they have traded in BATM thus far this morning in any size (and there are around a half dozen of them), JP Morgan stands out as one that never trades the name, so my best theory at this point is that the mega-firm had a sell basket of multiple names from a client and just put their BATM business on the book and accepted whatever price they got as it was just one small name among many and speed was more important than price. |
Posted at 09/9/2023 17:06 by echoridge First off, let me be clear that the GARP story that is increasingly coming into focus here - the 3 rock-solid business foundation, the clutch of credible short- and medium-term catalysts, the pristine balance sheet, the improving comms under the new leadership, the prospect for u/g to Shore Cap's forecasts - are all more than enough for me to argue that this rally may just be getting started, but if we are going to share our favourite outside-the-box triggers that might independently lift the share price, then I offer the following as an alternative to a potential covid move: a return to the TASE 125. 2023 has been a pretty miserable year for Israeli equities, particularly vs almost all other developed markets, marked by the bankruptcy of over 80 high-tech companies (mostly private companies to be fair, but still very impactful) due to painfully high interest rates and a commensurate decline in capital availability. As a result, there are now several companies with market caps in the low $200millions and the smallest company, Oramed Pharm, is now below $125m in the TASE 125. On Friday, BATM went out at about $155m market cap. Now, we're still a long-shot for any number of reasons including that there could well be a number of other possible entrants that are bigger than BATM (and I can't be bothered to find out right now), and even if not, bvc may still not gain entry due to the 'free float' factor score that the exchange considers when making these decisions, etc. But remember, BATM's ejection from this very index almost exactly a year ago, saw over 7m net shares get sold on the rebalancing date, which caused far more damage to our share price than the fiasco with the FTSE-Russell index the previous year. So even if there is only a whiff of a chance that the TASE 125 decision reverses - especially relevant if our share price breaks out for whatever reason for a 20%+ run vs the index and its nearest competitors of course - I think it's worth just a tiny mention now, no? |
Posted at 08/9/2023 21:44 by icemaninvestor Hi Folks! It's been a while. Good to see some of the usual suspects still here. BVC was very kind to me in 2020, and I managed to sell the vast majority of my shares at over 1 quid during the height of covid.The recent spike in share price is nothing to do with BVC moving from being undervalued to fairer value. It is, again, due to Covid and the increased incidence, leading countries like France to encourage mask wearing once more. You will see that other diagnostic companies also spiked this week. If BVC really takes off in the coming weeks, please keep in mind that it could be due to another covid bubble, and make sure you sell before the inevitable dip. Just some friendly advice because, last time some investors like FSE misinterpreted the reason for the spike and missed out on taking big profits. Good luck all! |
Posted at 06/3/2023 17:10 by fse A tech business only a few steps away from a re-ratingA provider of medical laboratory systems expects to report growth in 2023 but needs to win further contracts to boost the share price March 6, 2023 By Simon Thompson Annual revenue from ongoing operations declines by 12.7 per cent to $116mn Underlying operating profit falls from $11.3mn to $3.7mn $26mn cyber security order awarded post-year-end Net cash of $40mn (7.5p a share) Analysts rein back 2023 expectations It’s all change at BATM Advanced Communications (BVC:25.5p), a provider of medical laboratory systems, diagnostic kits, cyber security and network solutions. Former finance director Moti Nagar became chief executive at the start of 2023, replacing Zvi Marom, who is now a non-executive director. Ran Noy, who joined the group in 2021 as vice president for finance and has been working alongside Nagar, has been promoted to finance director. Their first task has been explaining last year’s profit reversal. In a trading update released just before the financial year-end, BATM revealed that a $25mn (£21mn) diagnostics contract, primarily Covid kits and products, that was due to be awarded from a customer in Southeast Asia, was still awaiting signature, thus creating a revenue shortfall. In addition, the strengthening of the US dollar against local currencies has produced a currency headwind at a time that both demand and market prices for Covid-related products have been softening. As a result, BATM’s bio-medical division (76 per cent of total revenue) reported 21 per cent lower annual revenue of $88.3mn, reflecting a sharp decline (from $37.1mn to $8.4mn year on year) in higher-margin Covid-related product sales. The fall in divisional operating profit from $17mn to $4.6mn also reflected the lower gross margin earned (29.4 per cent, down from 36.5 per cent). Looking at the positives There are positives, though. The group’s networking and cyber division narrowed its underlying operating loss from $5.6mn to £0.9mn on a third higher revenue of $27.9mn. BATM’s edge computing and network function virtualisation product suite, Edgility, is gaining real traction, signing a five-year initial order worth $3.5mn with CityFibre, the UK's largest independent carrier-neutral full fibre platform. The contract award is expected to be materially expanded as Edgility is rolled out across CityFibre’s full network. Moreover, Edgility has signed two other five-year contracts worth $2.7mn with other clients and is in “advanced discussions with several potential customers having undertaken proof-of-concept trials”. The group’s cyber security unit is in demand, too, lifting revenue 73 per cent year on year and landing a $26mn five-year government defence contract post-period end. The directors expect the networking and cyber unit to report an operating profit in 2023 and note that the current order backlog across the group is significantly higher than at this point last year. Forecasts downgraded That said, analysts at house broker Shore Capital expect to rein in their current-year revenue estimates by 22 per cent to $132mn to factor in ongoing currency headwinds that could reduce euro-related sales by $12mn (mainly in the bio-medical division) and to strip out the $25mn diagnostic tender from forecasts. On this basis, expect their 2023 pre-tax profit estimate to be slashed by two-thirds to $5.8mn, albeit this is still three times higher than the 2022 result. Clearly, much has changed since I rated BATM’s shares a recovery buy, at 27.5p, at the interim results (‘On the hunt for tech bargains’, 25 August 2022), not least the hefty downgrades to 2023 guidance, which mean that the shares, at 25.5p, are now trading on a 2023 price/earnings (PE) ratio of 47.5, or a cash-adjusted PE ratio of 33. BATM needs to win further contracts and raise guidance for the share price to make progress. That’s not a forlorn possibility, but the share price could tread water at the current level until that happens. Hold. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: +44 (0) 203 8794 460 | support@advfn.com |
ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
ADVFN France ADVFN US ADVFN Korea |